Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Camisa

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Nature Genetics|May 1, 1996
A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndromeE Maestrini, A P Monaco, J A McGrath, et al.
Journal of the American Academy of Dermatology|July 25, 2000
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?G G Krueger, S R Feldman, C Camisa, et al.
Journal of the American Academy of Dermatology|October 1, 1996
Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of DermatologyL A Drake, S M Dinehart, E R Farmer, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Guidelines of care for dermatomyositis. American Academy of DermatologyL A Drake, S M Dinehart, E R Farmer, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Guidelines of care for cutaneous lupus erythematosus. American Academy of DermatologyL A Drake, S M Dinehart, E R Farmer, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Nature Genetics|May 1, 1996
A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndromeE Maestrini, A P Monaco, J A McGrath, et al.
Journal of the American Academy of Dermatology|July 25, 2000
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?G G Krueger, S R Feldman, C Camisa, et al.
Journal of the American Academy of Dermatology|October 1, 1996
Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of DermatologyL A Drake, S M Dinehart, E R Farmer, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Guidelines of care for dermatomyositis. American Academy of DermatologyL A Drake, S M Dinehart, E R Farmer, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Guidelines of care for cutaneous lupus erythematosus. American Academy of DermatologyL A Drake, S M Dinehart, E R Farmer, et al.
Pageof 13